Cellectis (CLLS) Exchange Rate Effect (2014 - 2026)
Cellectis (CLLS) recorded quarterly Exchange Rate Effect of -$217000.0 in Q1 2026, down 116.19% quarter-over-quarter from $1.3 million in Q4 2025, and up 99.42% on a YoY basis from -$108816.8 in Q1 2025.
Cellectis (CLLS) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Cellectis' Exchange Rate Effect history runs 13 years deep, the most recent figure standing at -$217000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 99.42% year-over-year to -$217000.0; the TTM figure through Mar 2026 stood at $774000.0 (up 102.08% YoY), while the FY2025 annual figure was -$33.3 million, up 15.73% from the prior year.
- Exchange Rate Effect was -$217000.0 for Q1 2026 at Cellectis, down from $1.3 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.0 million in Q4 2022 to a low of -$38.1 million in Q2 2024.
- Historically, Exchange Rate Effect has averaged -$22.4 million across 5 years, with a median of -$32.7 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect jumped 184.23% in 2022, then tumbled 3250.0% in 2023.
- A 5-year view of Exchange Rate Effect shows it stood at $2.0 million in 2022, then decreased by 14.36% to $1.7 million in 2023, then sank by 220.46% to -$2.1 million in 2024, then soared by 165.21% to $1.3 million in 2025, then slumped by 116.19% to -$217000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$217000.0 (Q1 2026), $1.3 million (Q4 2025), and -$32.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | -217,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -217,000.00 |
| Mar 31, 2026 | -217,000.00 |
| Dec 31, 2025 | 1.34 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | -32.73 Mn |
| Sep 30, 2025 | -32.73 Mn |
| Jun 30, 2025 | -33.89 Mn |
| Jun 30, 2025 | -33.89 Mn |
| Mar 31, 2025 | -37.27 Mn |
| Mar 31, 2025 | -37.27 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Sep 30, 2024 | -35.15 Mn |
| Sep 30, 2024 | -35.15 Mn |
| Jun 30, 2024 | -38.08 Mn |
| Jun 30, 2024 | -38.08 Mn |
| Mar 31, 2024 | -37.24 Mn |
| Mar 31, 2024 | -37.24 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Dec 31, 2023 | 1.71 Mn |